- Home
- CAPR vs OOMA Comparison
CAPR vs OOMA Comparison
Compare CAPR & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- OOMA
- Stock Information
- Founded
- CAPR 2005
- OOMA 2003
- Country
- CAPR United States
- OOMA United States
- Employees
- CAPR N/A
- OOMA N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- OOMA EDP Services
- Sector
- CAPR Health Care
- OOMA Technology
- Exchange
- CAPR Nasdaq
- OOMA Nasdaq
- Market Cap
- CAPR 332.5M
- OOMA 296.9M
- IPO Year
- CAPR N/A
- OOMA 2015
- Fundamental
- Price
- CAPR $19.65
- OOMA $13.21
- Analyst Decision
- CAPR Strong Buy
- OOMA Strong Buy
- Analyst Count
- CAPR 6
- OOMA 4
- Target Price
- CAPR $35.50
- OOMA $14.67
- AVG Volume (30 Days)
- CAPR 1.9M
- OOMA 69.4K
- Earning Date
- CAPR 11-13-2024
- OOMA 12-03-2024
- Dividend Yield
- CAPR N/A
- OOMA N/A
- EPS Growth
- CAPR N/A
- OOMA N/A
- EPS
- CAPR N/A
- OOMA N/A
- Revenue
- CAPR $27,152,218.00
- OOMA $248,160,000.00
- Revenue This Year
- CAPR N/A
- OOMA $9.85
- Revenue Next Year
- CAPR $135.53
- OOMA $6.59
- P/E Ratio
- CAPR N/A
- OOMA N/A
- Revenue Growth
- CAPR 187.15
- OOMA 8.66
- 52 Week Low
- CAPR $2.68
- OOMA $6.50
- 52 Week High
- CAPR $23.40
- OOMA $13.49
- Technical
- Relative Strength Index (RSI)
- CAPR 53.80
- OOMA 71.45
- Support Level
- CAPR $17.50
- OOMA $11.95
- Resistance Level
- CAPR $20.37
- OOMA $12.65
- Average True Range (ATR)
- CAPR 1.57
- OOMA 0.32
- MACD
- CAPR -0.73
- OOMA 0.03
- Stochastic Oscillator
- CAPR 24.91
- OOMA 78.83
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service ("SaaS") and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. Ooma generates revenues from the sale of subscriptions and other services.